ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis B Vaccination Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-26J12976
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hepatitis B Vaccination Market Research Report 2023
BUY CHAPTERS

Global Hepatitis B Vaccination Market Research Report 2025

Code: QYRE-Auto-26J12976
Report
January 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute

Hepatitis B Vaccination Market Size

The global market for Hepatitis B Vaccination was valued at US$ 1094 million in the year 2024 and is projected to reach a revised size of US$ 1212 million by 2031, growing at a CAGR of 1.5% during the forecast period.

Hepatitis B Vaccination Market

Hepatitis B Vaccination Market

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
The hepatitis B vaccination market is driven by the increasing focus on disease prevention and the rising awareness of the importance of immunization. Hepatitis B vaccines provide essential protection against the hepatitis B virus (HBV), which can cause chronic liver infections and increase the risk of liver cirrhosis and cancer. The rise in the prevalence of hepatitis B infections and the need for effective control of the disease contribute to market growth as vaccination plays a crucial role in reducing transmission and preventing complications. Moreover, advancements in vaccine technology, such as the development of combination vaccines and birth dose administration, have improved vaccine accessibility and coverage. However, the market also faces challenges, including vaccine supply limitations and the need for ongoing public health initiatives to address barriers to vaccination, such as vaccine hesitancy and lack of awareness. Additionally, ensuring equitable access to hepatitis B vaccines and increasing vaccination rates in high-risk populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable hepatitis B vaccines, collaborate with healthcare providers and governments to implement vaccination programs, and address the challenges to meet the increasing demand for effective and accessible protection against hepatitis B.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccination.
The Hepatitis B Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis B Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hepatitis B Vaccination Market Report

Report Metric Details
Report Name Hepatitis B Vaccination Market
Accounted market size in year US$ 1094 million
Forecasted market size in 2031 US$ 1212 million
CAGR 1.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Yeast Derived
  • CHO Derived
Segment by Application
  • Children
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences, Serum Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hepatitis B Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hepatitis B Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hepatitis B Vaccination Market growing?

Ans: The Hepatitis B Vaccination Market witnessing a CAGR of 1.5% during the forecast period 2025-2031.

What is the Hepatitis B Vaccination Market size in 2031?

Ans: The Hepatitis B Vaccination Market size in 2031 will be US$ 1212 million.

Who are the main players in the Hepatitis B Vaccination Market report?

Ans: The main players in the Hepatitis B Vaccination Market are GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences, Serum Institute

What are the Application segmentation covered in the Hepatitis B Vaccination Market report?

Ans: The Applications covered in the Hepatitis B Vaccination Market report are Children, Adult

What are the Type segmentation covered in the Hepatitis B Vaccination Market report?

Ans: The Types covered in the Hepatitis B Vaccination Market report are Yeast Derived, CHO Derived

Recommended Reports

Hepatitis-Related Markets

Vaccine Technology

Other Infectious Vaccines

1 Hepatitis B Vaccination Market Overview
1.1 Product Definition
1.2 Hepatitis B Vaccination by Type
1.2.1 Global Hepatitis B Vaccination Market Value Comparison by Type (2024 VS 2031)
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Hepatitis B Vaccination by Application
1.3.1 Global Hepatitis B Vaccination Market Value by Application (2024 VS 2031)
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis B Vaccination Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Vaccination Revenue 2020-2031
1.4.2 Global Hepatitis B Vaccination Sales 2020-2031
1.4.3 Global Hepatitis B Vaccination Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hepatitis B Vaccination Market Competition by Manufacturers
2.1 Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hepatitis B Vaccination Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hepatitis B Vaccination Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hepatitis B Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis B Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis B Vaccination, Product Type & Application
2.7 Global Key Manufacturers of Hepatitis B Vaccination, Date of Enter into This Industry
2.8 Global Hepatitis B Vaccination Market Competitive Situation and Trends
2.8.1 Global Hepatitis B Vaccination Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hepatitis B Vaccination Players Market Share by Revenue
2.8.3 Global Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hepatitis B Vaccination Market Scenario by Region
3.1 Global Hepatitis B Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hepatitis B Vaccination Sales by Region: 2020-2031
3.2.1 Global Hepatitis B Vaccination Sales by Region: 2020-2025
3.2.2 Global Hepatitis B Vaccination Sales by Region: 2026-2031
3.3 Global Hepatitis B Vaccination Revenue by Region: 2020-2031
3.3.1 Global Hepatitis B Vaccination Revenue by Region: 2020-2025
3.3.2 Global Hepatitis B Vaccination Revenue by Region: 2026-2031
3.4 North America Hepatitis B Vaccination Market Facts & Figures by Country
3.4.1 North America Hepatitis B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hepatitis B Vaccination Sales by Country (2020-2031)
3.4.3 North America Hepatitis B Vaccination Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis B Vaccination Market Facts & Figures by Country
3.5.1 Europe Hepatitis B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hepatitis B Vaccination Sales by Country (2020-2031)
3.5.3 Europe Hepatitis B Vaccination Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis B Vaccination Market Facts & Figures by Region
3.6.1 Asia Pacific Hepatitis B Vaccination Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hepatitis B Vaccination Sales by Region (2020-2031)
3.6.3 Asia Pacific Hepatitis B Vaccination Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis B Vaccination Market Facts & Figures by Country
3.7.1 Latin America Hepatitis B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hepatitis B Vaccination Sales by Country (2020-2031)
3.7.3 Latin America Hepatitis B Vaccination Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis B Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis B Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hepatitis B Vaccination Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hepatitis B Vaccination Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis B Vaccination Sales by Type (2020-2031)
4.1.1 Global Hepatitis B Vaccination Sales by Type (2020-2025)
4.1.2 Global Hepatitis B Vaccination Sales by Type (2026-2031)
4.1.3 Global Hepatitis B Vaccination Sales Market Share by Type (2020-2031)
4.2 Global Hepatitis B Vaccination Revenue by Type (2020-2031)
4.2.1 Global Hepatitis B Vaccination Revenue by Type (2020-2025)
4.2.2 Global Hepatitis B Vaccination Revenue by Type (2026-2031)
4.2.3 Global Hepatitis B Vaccination Revenue Market Share by Type (2020-2031)
4.3 Global Hepatitis B Vaccination Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hepatitis B Vaccination Sales by Application (2020-2031)
5.1.1 Global Hepatitis B Vaccination Sales by Application (2020-2025)
5.1.2 Global Hepatitis B Vaccination Sales by Application (2026-2031)
5.1.3 Global Hepatitis B Vaccination Sales Market Share by Application (2020-2031)
5.2 Global Hepatitis B Vaccination Revenue by Application (2020-2031)
5.2.1 Global Hepatitis B Vaccination Revenue by Application (2020-2025)
5.2.2 Global Hepatitis B Vaccination Revenue by Application (2026-2031)
5.2.3 Global Hepatitis B Vaccination Revenue Market Share by Application (2020-2031)
5.3 Global Hepatitis B Vaccination Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Hepatitis B Vaccination Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Company Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.2.4 NCPC Hepatitis B Vaccination Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Hepatitis B Vaccination Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Company Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bio Kangtai Hepatitis B Vaccination Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Company Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dynavax Hepatitis B Vaccination Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 Hissen
6.6.1 Hissen Company Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hissen Hepatitis B Vaccination Product Portfolio
6.6.5 Hissen Recent Developments/Updates
6.7 KM Biologics
6.7.1 KM Biologics Company Information
6.7.2 KM Biologics Description and Business Overview
6.7.3 KM Biologics Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.7.4 KM Biologics Hepatitis B Vaccination Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Company Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LG Life Sciences Hepatitis B Vaccination Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Company Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Hepatitis B Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Serum Institute Hepatitis B Vaccination Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis B Vaccination Industry Chain Analysis
7.2 Hepatitis B Vaccination Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis B Vaccination Production Mode & Process Analysis
7.4 Hepatitis B Vaccination Sales and Marketing
7.4.1 Hepatitis B Vaccination Sales Channels
7.4.2 Hepatitis B Vaccination Distributors
7.5 Hepatitis B Vaccination Customer Analysis
8 Hepatitis B Vaccination Market Dynamics
8.1 Hepatitis B Vaccination Industry Trends
8.2 Hepatitis B Vaccination Market Drivers
8.3 Hepatitis B Vaccination Market Challenges
8.4 Hepatitis B Vaccination Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
List of Tables
 Table 1. Global Hepatitis B Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hepatitis B Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hepatitis B Vaccination Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hepatitis B Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hepatitis B Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hepatitis B Vaccination Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hepatitis B Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hepatitis B Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hepatitis B Vaccination, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hepatitis B Vaccination, Product Type & Application
 Table 12. Global Key Manufacturers of Hepatitis B Vaccination, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hepatitis B Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccination as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hepatitis B Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hepatitis B Vaccination Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hepatitis B Vaccination Sales Market Share by Region (2020-2025)
 Table 19. Global Hepatitis B Vaccination Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hepatitis B Vaccination Sales Market Share by Region (2026-2031)
 Table 21. Global Hepatitis B Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hepatitis B Vaccination Revenue Market Share by Region (2020-2025)
 Table 23. Global Hepatitis B Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hepatitis B Vaccination Revenue Market Share by Region (2026-2031)
 Table 25. North America Hepatitis B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hepatitis B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hepatitis B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hepatitis B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hepatitis B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hepatitis B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hepatitis B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hepatitis B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hepatitis B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hepatitis B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hepatitis B Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hepatitis B Vaccination Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hepatitis B Vaccination Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hepatitis B Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hepatitis B Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hepatitis B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hepatitis B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hepatitis B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hepatitis B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hepatitis B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hepatitis B Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hepatitis B Vaccination Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hepatitis B Vaccination Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hepatitis B Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hepatitis B Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hepatitis B Vaccination Sales (K Units) by Type (2020-2025)
 Table 51. Global Hepatitis B Vaccination Sales (K Units) by Type (2026-2031)
 Table 52. Global Hepatitis B Vaccination Sales Market Share by Type (2020-2025)
 Table 53. Global Hepatitis B Vaccination Sales Market Share by Type (2026-2031)
 Table 54. Global Hepatitis B Vaccination Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hepatitis B Vaccination Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hepatitis B Vaccination Revenue Market Share by Type (2020-2025)
 Table 57. Global Hepatitis B Vaccination Revenue Market Share by Type (2026-2031)
 Table 58. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hepatitis B Vaccination Sales (K Units) by Application (2020-2025)
 Table 61. Global Hepatitis B Vaccination Sales (K Units) by Application (2026-2031)
 Table 62. Global Hepatitis B Vaccination Sales Market Share by Application (2020-2025)
 Table 63. Global Hepatitis B Vaccination Sales Market Share by Application (2026-2031)
 Table 64. Global Hepatitis B Vaccination Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hepatitis B Vaccination Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hepatitis B Vaccination Revenue Market Share by Application (2020-2025)
 Table 67. Global Hepatitis B Vaccination Revenue Market Share by Application (2026-2031)
 Table 68. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Hepatitis B Vaccination Product
 Table 74. GSK Recent Developments/Updates
 Table 75. NCPC Company Information
 Table 76. NCPC Description and Business Overview
 Table 77. NCPC Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. NCPC Hepatitis B Vaccination Product
 Table 79. NCPC Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Hepatitis B Vaccination Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Bio Kangtai Company Information
 Table 86. Bio Kangtai Description and Business Overview
 Table 87. Bio Kangtai Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bio Kangtai Hepatitis B Vaccination Product
 Table 89. Bio Kangtai Recent Developments/Updates
 Table 90. Dynavax Company Information
 Table 91. Dynavax Description and Business Overview
 Table 92. Dynavax Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Dynavax Hepatitis B Vaccination Product
 Table 94. Dynavax Recent Developments/Updates
 Table 95. Hissen Company Information
 Table 96. Hissen Description and Business Overview
 Table 97. Hissen Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hissen Hepatitis B Vaccination Product
 Table 99. Hissen Recent Developments/Updates
 Table 100. KM Biologics Company Information
 Table 101. KM Biologics Description and Business Overview
 Table 102. KM Biologics Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. KM Biologics Hepatitis B Vaccination Product
 Table 104. KM Biologics Recent Developments/Updates
 Table 105. LG Life Sciences Company Information
 Table 106. LG Life Sciences Description and Business Overview
 Table 107. LG Life Sciences Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. LG Life Sciences Hepatitis B Vaccination Product
 Table 109. LG Life Sciences Recent Developments/Updates
 Table 110. Serum Institute Company Information
 Table 111. Serum Institute Description and Business Overview
 Table 112. Serum Institute Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Serum Institute Hepatitis B Vaccination Product
 Table 114. Serum Institute Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Hepatitis B Vaccination Distributors List
 Table 118. Hepatitis B Vaccination Customers List
 Table 119. Hepatitis B Vaccination Market Trends
 Table 120. Hepatitis B Vaccination Market Drivers
 Table 121. Hepatitis B Vaccination Market Challenges
 Table 122. Hepatitis B Vaccination Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hepatitis B Vaccination
 Figure 2. Global Hepatitis B Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hepatitis B Vaccination Market Share by Type: 2024 & 2031
 Figure 4. Yeast Derived Product Picture
 Figure 5. CHO Derived Product Picture
 Figure 6. Global Hepatitis B Vaccination Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hepatitis B Vaccination Market Share by Application: 2024 & 2031
 Figure 8. Children
 Figure 9. Adult
 Figure 10. Global Hepatitis B Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Hepatitis B Vaccination Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Hepatitis B Vaccination Sales (2020-2031) & (K Units)
 Figure 13. Global Hepatitis B Vaccination Average Price (US$/Unit) & (2020-2031)
 Figure 14. Hepatitis B Vaccination Report Years Considered
 Figure 15. Hepatitis B Vaccination Sales Share by Manufacturers in 2024
 Figure 16. Global Hepatitis B Vaccination Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Hepatitis B Vaccination Players: Market Share by Revenue in Hepatitis B Vaccination in 2024
 Figure 18. Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Hepatitis B Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Hepatitis B Vaccination Sales Market Share by Country (2020-2031)
 Figure 21. North America Hepatitis B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 22. United States Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Hepatitis B Vaccination Sales Market Share by Country (2020-2031)
 Figure 25. Europe Hepatitis B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Hepatitis B Vaccination Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Hepatitis B Vaccination Revenue Market Share by Region (2020-2031)
 Figure 33. China Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Hepatitis B Vaccination Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Hepatitis B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Hepatitis B Vaccination Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Hepatitis B Vaccination Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Hepatitis B Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Hepatitis B Vaccination by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Hepatitis B Vaccination by Type (2020-2031)
 Figure 54. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Hepatitis B Vaccination by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Hepatitis B Vaccination by Application (2020-2031)
 Figure 57. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2020-2031)
 Figure 58. Hepatitis B Vaccination Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Hepatitis B Vaccines Market
Recombinant Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A Vaccination Market Research Report 2025
Hepatitis A Vaccine Market
Global Hepatitis B Human Immunoglobulin Market Research Report 2024
Global Hepatitis B Treatment Market Insights Forecast to 2030
Mono Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A and B Vaccination Market Research Report 2025
Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A and B Vaccine Market Research Report 2025
Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mono Hepatitis A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inactivated Hepatitis A Vaccine Market Research Report 2024
Hepatitis B Infectious Disease Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis B Immune Globulin Market Research Report 2025
Global Human Hepatitis B Immunoglobulin for Intravenous Injection Market Research Report 2024
Hepatitis B Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Vaccines Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions